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1). Singhirunnusorn P., Suzuki S., Kawasaki N., Saiki I., and Sakurai H: Critical roles of 
threonine-187 phosphorylation in cellular stress-induced rapid and transient activation of 
transforming growth factor-J3-activated kinase 1 (TAKl) in a signaling complex containing 
TAKl・bindingprotein TABl and TAB2. J. Biol. Chem. 280: 7359-7368, 2005. 
Abstract: Transforming growth factor-beta-activated kinase 1 (TAK 1) mitogerトactivatedprotein kinase 
kinase kinase has been shown to be activated by cellular stresses including tumor necrosis factor-alpha 
(TNF・alpha).Here, we characterized the molecular mechanisms of cellular stress-induced TAKI 
activation, focusing mainly on the phosphorylation of TAKI at Thr”187 and Ser-192 in the activation 
loop. Thr-187 and Ser-192 are conserved among species from Caenorhabditis elegans to human, and their 
replacement with Ala resulted in inactivation of TAK 1.Immunoblotting with a novel phospho-TAK 1 
antibody revealed that TNF-alpha significantly induced the phosphorylation of endogenous TAKl at 
Thr-187, and subsequently the phosphorylated forms of TAKl rapidly disappeared. Intermolecular 
autophosphorylation of Thr-187 was essential for TAKl activation. RNA interference and overexpression 
experiments demonstrated that TAKl-binding protein TABl and TAB2 were involved in the 
phosphorylation of TAKl, but they regulated TAKl phosphorylation differentially. Furthermore, 
SB203580 and p38alpha small interfering RNA enhanced TNF-alpha-induced Thr-187 phosphorylation 
as well as TAKl kinase activity, indicating that the phosphorylation is affected by 
p38alpha/TAB1/TAB2-mediated feedback control of TAKI. These results indicate critical roles of 
Thr-187 phospho巧rlationin the stress-induced rapid and transient activation of TAKl in a signaling 
complex containing TAB 1 and TAB2. 
2) Chino A, Sakurai H., Matsuo M., Choo M-K., Koizumi K., Shimada Y., Terasawa K., and 
Saiki I.: Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating 
Toll帽likereceptor 4 signalling pathways in murine peritoneal exudates macrophages. Int. 
Immunopharmacol., 5: 871・882,2005. 
Abstract: Juzentaihoto (TJ・48),a Kampo medicineラhasbeen reported to affect the immune system. 
Although toll-like receptors (TLRs) have been identified as receptors of innate immunity, the effects of 
TJ-48 on TLR signaling pathways have not been thoroughly investigated. Here we evaluated the effects 
ofTJ-48 on TLR4 signaling pathways. Peritoneal exudate macrophages (PEMs) isolated from mice orally 
administered TJ-48 for 1 days were stimulated with lipopolysaccharide (LPS), a ligand of TLR4, in 
vitro. Production oflL-12 p40 was significantly augmented in TJ・48・treatedPEMs compared with that in 
vehicle PEMs, without affecting the surface expression of TLR4. Treatment with chemical inhibitors of 
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NF-kappa Band p38 mitogen-activated protein kinases (MAPKs) in vitro inhibited LPS-induced IL-12 
production, whereas JNK and ERK inhibitors increased IL-12 production. Immunoblotting with 
phosphorylation-state specific antibodies demonstrated that TJ-48 differentially affected LPS”induced 
phosphorylation of NF-kappa Band MAPKs. In PEMs treated with TJ-48, LPS・inducedphosphorylation 
of p65 NF-kappa B and p38 MAPK was augmented, while that of JNK and ERK was attenuated 
compared with those in vehicle PEMs. These results suggest that selective modulation of the TLR4 
signaling pathways by TJ-48 is involved in enhanced production ofIL-12 in PE恥1s.
3) Yoshioka I叫 TsuchiyaY., Aozuka Y., Ohnishi Y叫 SakuraiH., Koizumi K., Tsukada K., and 
Saiki I.: Urinary trypsin inhibitor suppresses surgical stress-facillitated lung metastasis of 
murine colon cel carcinoma, colon 26・L5cels. Anticancer Res., 25: 815-820, 2005. 
Abstract: Recently, we have reported that surgical stress promoted the metastasis of murine colon 
carcinoma cells to the lung by inducing the expression of proteases such as matrix metalloprotease-9 
(MMP-9) in lung tissue. Urinary trypsin inhibitor (UTI) is a serine protease inhibitor frequently used to 
treat pancreatitis and to improve the microcirculatory environment. The purpose of this study was to 
investigate the anti-metastatic properties of UTI in an animal model of surgical stress-induced cancer 
metastasis. The intraperitoneal administration of UTI after the intravenous injection of colon 26-L5 
carcinoma (colon 26-L5) cells into mice subjected to surgical stress suppressed the enhancement of lung 
metastasis (p<0.05). Furthermoreラ weinvestigated the effect of UTI on tumor growthラ adhesionto 
fibronectin, migration, invasion and enzymatic degradation in colon 26-L5. UTI reduced the invasive 
ability and the degradation by MMP-9 of gelatin substrate in colon 26-L5 cels. UTI may improve 
therapeutic efficacy in cancer patients after major surgery. 
4) Lirdprapamongkol K, Sakurai H., Kawasaki N., Choo M-K, Saitoh Y叫 AozukaY., 
Singhirunnusorn P., Ruchirawat S., Svasti J., and Saiki I.: Vanillm suppresses tumor 
invasion and metastasis of breast cancer cels. Eur. I. Pharm. Sci., 25: 57-65, 2005. 
Abstract: Vanillin, a food flavoring agent, has been reported to show anti-mutagenic activity and to 
inhibit chemical carcinogenesis. In this s如dy,we examined the effect of vanillin on the growth and 
metastasis of 4Tl mammary adenocarcinoma cells in BALB/c mice. Mice orally administered with 
vanillin showed significantly reduced numbers of lung metastasized colonies compared to controls. In 
vitro studies revealed that vanillin, at concentrations that were not cytotoxic, inhibited invasion and 
migration of cancer cells and inhibited enzymatic activity ofMMP-9 secreted by the cancer cels. Van il in 
also showed growth inhibitory effect towards cancer cells in vitro. However, vanillic acid, a major 
metabolic product of vanillin in human and rat, was not active in these in vitro activity assays. Our 
findings suggest that vanillin has anti-metastatic potential by decreasing invasiveness of cancer cels. 
Since vanillin is generally regarded as safe, it may be of value in the development of anti岨metastaticdrugs 
for cancer treatment. 
5) Nagakawa 0., Junicho A., Akashi T., Koizumi K., Matsuda T., Fuse H., and Saiki I.: 
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide 
stimulate interleukin-6 production in prostate cancer and prostatic epithelial cels. Oncology 
Rep., 23: 1217・1221,2005. 
6) Ueno Y., Sakurai H., Matsuo M., Choo RιK., Koizumi k叫 andSaiki I.: Selective inhibition 
of TNF－α－induced activation of mitogen-activated protein kinases and metastatic activities 
by gefitinib. Bκi Cancer, 92: 1690・1695,2005. 
Abstract: We have reported that the selective epidermal growth factor receptor (EGFR) tyrosine kinase 
inhibitor, gefitinib ('Iresa', ZD 1839), suppressed intrahepatic metastasis of hepatocellular carcinoma 
CBO l 40C 12 cels. In this study, we focused on the tumour necrosis factor-alpha (TNF-alpha) signalling 
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pathways. Real-time reverse transcription-polymerase chain reaction showed that TNF-alpha mRNA was 
expressed in large quantities in the implanted tumour. Gefitinib inhibited EGF-but not hepatocyte growth 
factor (HG F）ーinducedactivation of mitogen-activated protein kinase (MAPK) cascades, suggesting 
selectivity of the inhibitor. However, gefitinib inhibited the TNF-alpha-induced activation ofMAPKs and 
Akt. In addition, TNF-alpha-induced metastatic properties including adhesion to fibronectin, mRNA 
expression of integrin alpha v, production of matrix metalloproteinase-9 and invasion were inhibited by 
gefitinib without affecting cel proliferation. Furthermore, the TNF-alpha-induced responses except for 
NF-kappaB activation were blocked by metalloprotease inhibitors, suggesting that gefitinib inhibited the 
transactivation of EGFR induced by TNF-alpha. These results suggest that the TNF-alpha signalling 
pathway is a possible target of gefitinib in suppressing the intrahepatic metastasis of hepatocellular 
carcinoma. 
7) Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y., Ogawa K., Goto H., and Saiki 
I.: Expression pattern of plasma .proteins in spontaneously diabetic rats after oral 
administration of a Kampo medicine, Hachimi-jio・gan,using SELDI ProteinChip platform. 
Biol. Pharm. Bull., 28: 1031-1037, 2005. 
Abstract: We investigated the changes (increase or decrease in peak intensity) in the expression of 
plasma proteins in spontaneously diabetic WBN/Kob rats that were with complicated diabetic 
nephropathy, to determine multiple biomarkers in the plasma of diabetic rats. The present study using 
surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) 
demonstrated that six peaks at mass/charge ratios (m/z) of 4678ラ4732,4808, 9058, 9323, and 9465, 
among approximately 80 peaks per spectrum in the 2000-10000 Da mass range, had increased peak 
intensities with the development or progression of diabetic nephropathy in plasma of spontaneously 
diabetic WBN/Kob rats as compared with those of normal Wistar rats. Administration of the Kampo 
medicine Hachimi-jio-gan was effective at reducing the expression of diabetic nephropathy but not at 
reducing blood glucose levels. It also improved the increased levels of these plasma proteins. Other 
biomarker peaks at m/z 5067, 5279ラ7598,and 7917 were not affected by Hachimi-jio-gan administration. 
Further study will be needed to identify these positive biomarkers and to evaluate the relationship 
between the efficacy and expression patterns of the plasma proteins in greater detail. The expression 
patterns of proteins and molecular-related ions revealed that several proteins in plasma may be involved 
in the development and/or progression of diabetic nephropathy in WBN/Kob rats and the efficacy of 
Hachimi-jio-gan. This study using ProteinChip technology may provide a useful basis in the search for 
multiple biomarkers in plasma for the diagnosis of disease and therapeutic evaluation of Kampo 
medicines. 
8) Goto H., Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y. Ogawa K., Shibahara 
N., Shimada Y., and Saiki I.: Effects of two formulations for overcoming oketsu on vascular 
function and expression patterns of plasma proteins in spontaneously diabetic rats. J. Trad. 
Med., 22: 237-243, 2005. 
Abstract: We investigated the effects of keishibukuryogan and tokishakuyakusan, which are 
representative formulations for overcoming oketsu, on vascular function and expression patterns of 
plasma proteins in spontaneously diabetic rats. Twenty-one-to 24-week-old male WBN/Kob rats were 
maintained for 18 weeks on a diabetes-accelerated feed, and received standard chow containing 3% 
(wt/wt) keishibukuryogan or tokishakuyakusan for 25 weeks. There was no significant change in body 
weight or blood glucose among the groups. Acetylcholine-induced endothelium-dependent relaxation of 
the keishibukuryogan group significantly increased compared to that of controls. Xanthine/xanthine 
oxidase-induced contraction of the tokishakuyakusan group and phospholipase Arinduced contraction of 
the keishibukuryogan and tokishakuyakusan groups significantly decreased compared to the controls. 
Transit time of whole blood tended to decrease in the tokishakuyakusan group compared to controls. 
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N02-/N03-in the keishibukuryogan and tokishakuyakusan groups significantly decreased compared to 
controls. A study using surface enhanced laser desorption/ionization time-of-flight mass spectrometry 
(SELDI-TOF-MS) demonstrated that five and eight peaks had significantly changed peak intensities in 
plasma of rats treated with keishibukuryogan and tokishakuyakusan, respectively, as compared to the 
controls. Thus, two representative formulations for overcoming oketsu with different mechanisms of 
action had favorable effects against vascular dysfunction. Altered plasma protein levels were commonly 
observed in the rats administered these two formulations. Our study using ProteinChip technology may 
be useful for the evaluation of the relationship between the e ficacy and the profiling of plasma protein 
expression after administration Kampo medicines, thus leading to the understanding of “Sho”in Kampo 
medicine. 
9) Tega E., Kiga C. Chino A., Sakurai H., Koizumi K., Tani T., and Saiki I.: A newly devised 
formulation for self-medication enhances interferon圃 productionand proliferation of splenic 
lymphocytes. Biol. Pharm. Bull., 28: 1869・1872,2005. 
Abstract: A newly devised formulation for self-medication in Toyama, Pana Wang, is a new herbal 
medicine (so called Toyama original brand formulation) developed based on traditional philosophy and 
scientific evidence. We here tried to examine the effect of oral administration of Pana Wang on the balance 
of type I helper T cells (Thl) and Th2 cels. Splenic lymphocytes 仕omnormal mice were stimulated with 
Concanavalin A (Con A) in vitro and the secretion of Thl-and Th2-type cytokines, interferon-gamma 
(IFN-gamma) and interleukin-4 (IL-4) respectively, was investigated. Con A聞inducedproduction of 
IFN-gamma 企omspleen cels, but not IL-4, was enhanced by the administration of Pana Wang. Increased 
production of IFN-gamma was also detected in splenic lymphocytes 丘omTh2-predominant BALB/c 
mice after DNP-immunization, without a change in antigen-specific IgE levels in vivo. Antigen-specific 
proliferative responses were also increased in lymphocytes from Pana Wang-treated mice. These findings 
raise the possibility that Pana Wang has Thi-stimulating activity and induces Thi-predominant immunity. 
10) Schwabe R.F. and Sakurai H.: IKK phosphorylates p65 at S468 in transactivation domaip. 2 
FASEB J., 19: 1758-1760, 2005. 
Abstract: The transcription factor nuclear factor蜘kappaB (NF-kappaB) subunit p65 is phosphorylated 
by IkappaB kinase (IKK) at S536 in transactivation domain (TAD) I. In this study, we investigate the 
presence of IKK sites in TAD2 of p65. Recombinant IKKbeta, but not IKKalpha, phosphorylated a 
GST-p65 substrate in which TADI was deleted. Mutational analysis revealed S468 as the only IKK site in 
TAD2. S468 phosphorylation occurred rapidly after TNF-alpha and IL-I beta in T cel, B cel, cervix 
carcinoma, hepatoma, breast cancer, and astrocytoma lines and in primary hepatic stellate cells as well as 
peripheral blood mononuclear cels. S468”phosphorylated p65 coimmunoprecipitated with 
IkappaBalpha, indicating that p65 is phosphorylated while bound to IkappaBalpha. Dominant negative 
IKKbeta or pharmacological IKK inhibition blocked S468 phosphorylation after TNF-alpha or IL-I beta, 
whereas dominant negative IKKalpha or inhibitors of MEK, p38，応JK,PI-3 kinase, or GSK-3 had no 
effect. p65S468A-reconstituted p65-/-mouse embryonic fibroblasts (MEFs) showed a small, but 
significant, elevation of NF-kappaB-driven luciferase activity and RANTES mRNA levels after 
TNF-alpha and IL-I beta in comparison to wtp65-reconstituted MEFs. p65 nuclear translocation was not 
altered in p65S468A-expressing MEFs. In conclusion, our results indicate that I) IKKbeta 
phosphor》rlatesmultiple p65 sitesラ2)IKKbeta phosphorylates p65 in an IkappaB-p65 complex, and 3) 
S468 phosphorylation slightly reduces TNF-alpha-and IL-I beta帥inducedNF”kappaB activation. 
11) Choo M-K., Sakurai H., Koizumi K., and Saiki I.: Stimulation of cultured colon 26 cells with 
TNF－αpromotes lung metastasis through the extracellular signal-regulated kinase pathway. 
Cancer Lett., 230: 47・56,2005. 
Abstract: We investigated the influence of TNF-alpha on the metastasis of cancer cels. Treatment of 
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cultured colon 26 cells with TNF-alpha enhanced metastatic properties including production of MMP-9, 
adhesion, migration and invasion. Cells treated with TNF-alpha in vitro showed marked potential to 
metastasize to the lung and liver in vivo. U0126, an inhibitor of MEKl/2, inhibited the 
TNF-alpha-induced activation of extracellular signal-regulated kinase 1/2 (ERKI/2) and the metastatic 
properties in vitro without affecting cel proliferation. In addition, pretreatment with U0126 in vitro 
completely abrogated the increased lung metastasis of TNF-alpha-treated cels. These results indicate that 
TNF-alpha-induced activation of cancer cells through the ERK pathway is sufficient for the enhanced 
metastatic potential of colon 26 cels. 
12) Sakurai H., Singhirunnusorn P., Shimotabira E., Chino A., Suzuki S., Koizumi K., and Saiki 
I.: TAKl・mediatedtranscriptional activation of CD28・responsiveelement and AP-I-binding 
site within the IL・2promoter in Jurkat T cels. FEBS Let., 579: 6641・6646,2005. 
Abstract: We focused on the functional involvement of transforming growth factor-beta-activated kinase 
1 (TAKI) in transcriptional regulation of interleukin-2 (IL-2) in T cels. Costimulation of Jurkat cells with 
12-0-tetradecanoylphorbol-13-acetate and A23187 leads to a rapid phosphorylation of TAKI and 
TAKI-binding protein I (TABI), critical for TAKI activation. A specific inhibitor of TAKI blocked 
production of IL-2. In addition, overexpression of TAKI and TAB 1 induced secretion of IL四2.
CD28-responsive element/activator protein-I -binding site (RE/ AP) within the IL-2 promoter was a 
functional target for TAKI. The RE/ AP-driven transcription was regulated by TAKトmediatedactivation 
of the c-Jun NH2-terminal kinase, p38 and IkappaB kinase. These results indicate that TAKI plays a 
critical role in T cel activation by controlling production of IL-2. 
13) Ueda Y., Yamagishi T., Samata K., Hirayama N., Aozuka Y叫 TanakaM., N akaike S., and 
Saiki I.: Anti-tumor Effect of Synthetic VEGF Binding Antagonist, VGA1155. Anticancer 
Res., 25: 3973・3977,2005. 
Abstract: Vascular endothelial growth factor (VEGF) plays key roles in tumor angiogenesis. Therefore, 
VEGF and its receptors are considered to be primary targets for antiangiogenic strategy during cancer 
chemotherapy. Our previous study reported that VGA1155, a low-molecular-weight inhibitor of the 
binding of VEGF, inhibited VEGF binding to KDR/Flk司 Ireceptor-overexpressing cels. In the present 
studyラtheantitumor effects and antimetastatic effect of VGA1155 were examined in vivo. VGA1155 
suppressed the growth of human lung, breast, colon and epidermoid cancers (LC田6ラHT29,MX-1, Col-I 
and A43 I) in the nude mouse xenograft model, and pulmonary metastasis of melanoma in the 
spontaneous metastasis model. These results suggest that VGAI 155 has antitumor effects in vivo through 
the inhibition of VEGF binding to its receptors. 
14) Shinohara H., Yasuda T., Aiba Y., Sanjo H., Hamadate M., Watarai H., Sakurai H., and 
Kurosaki T.: PKC regulates BCR岨mediatedIKK activation by facilitating the interaction 
between TAKl and CARMAl. J. Exp. Med., 202: 1423・1431,2005. 
Abstract: The B cel antigen receptor (BCR)-mediated activation of IkappaB kinase (IKK) and nuclear 
factor-kappaB require protein kinase C (PKC)beta; however, the mechanism by which PKCbeta regulates 
IKK is unclear. Here, we demonstrate that another protein kinase, TGFbeta-activated kinase (TAK) 1, is 
essential for IKK activation in response to BCR stimulation. TAKI interacts with the phosphorylated 
CARMAI (also known as caspase recruitment domain [CARD]ll, Bimp3) and this interaction is 
mediated by PKCbeta. IKK is also recruited to the CARMAl-BcllO-mucosal-associated lymphoid tissue 
I adaptor complex in a PKCbeta-dependent manner. Hence, our data suggest that phosphorylation of 
CARMA 1,mediated by PKCbeta, brings同rokey protein kinases, TAKI and IKK, into close proximity, 
thereby allowing TAKI to phosphorylate IKK. 
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15) Blonska M., Shambharkar P.B., Kobayashi M., Zhang D., Sakurai H., Su B., and Lin X.: 
TAKI is recruited to the tumor necrosis factor－α （TNF・αfreceptor 1 in a 
receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading 
to NF-KB activation. J. Biol. Chem., 280: 43056-43063, 2005. 
Abstract: Receptor-interacting protein (RIP) plays a critical role in tumor necrosis factor-alpha 
(TNF-alpha)-induced IkappaB kinase (IKK) activation and subsequent activation of transcription factor 
NF-kappaB. However, the molecular mechanism by which RIP mediates TNF-alpha-induced NF-kappaB 
activation is not completely defined. In this studyラwehave found that TAKI is recruited to the TNF-alpha 
receptor complex in a RIP-dependent manner following the stimulation of TNF-alpha receptor 1 
(TNF-Rl). Moreover, a forced recruitment of TAKI to TNF-Rl in the absence of RIP is sufficient to 
mediate TNF-alpha-induced NF-kappaB activationうindicatingthat the major function of RIP is to recruit 
its downstream kinases to the TNF-Rl complex. Interestingly, we also find that TAKl and MEKK3 form 
a functional complex, in which TAKl regulates autophosphorylation of MEKK3. The TAKI-mediated 
regulation of MEKK3 phosphorylation is dependent on the kinase activity of TAK 1.Although 
TAK1-MEKK3 interaction is not affected by overexpressed TABl, TABl is required for TAKl activation 
and subsequent MEKK3 phosphorylation. Together, we conclude that TAKI is recruited to the TNF-Rl 
complex via RIP and likely cooperates with MEKK3 to activate NF-kappaB in TNF-alpha signaling. 
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下回平恵美： T細胞の IL-2産生におけるTGF-Bactivated kinase 1の役割
修士論文：
鈴木俊輔： NF-KBp65サブユニット Ser司536リン酸化の解析
上野陽子：肝細胞がんにおける TNF－αシグナル伝達および軒多能に及ぼすがitinib
の影響
膏藤百合花：癌細胞の接着と血管新生におけるAPN/CD13の役割
小林光夫：破骨細胞分化誘導に伴う CCL22/rnacrophage-derivedchernokine (MDC)の
産生とヒ卜小細胞肺癌株 SBC-5細胞の骨転移機構の解明
博士論文：
後藤若菜：緑内障治療薬塩酸ブナゾシンの視神経保護作用に関する研究
地野充時：マウス腹腔湾出マクロファージの Toll-likereceptor 4シグナル伝達経路
に及ぼす十全大補湯の効果
吉岡伊作：手術侵襲による癌転移増強の制御に関する基礎的模討
小林光夫：修士課程修了後、日清キョーljン製薬、研究員
下田平恵美：西尾薬局、富山
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